← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Medros, Inc.
St. Louis, MO
$1,004,456
Total funding
7
Grants
Funding over time
peak $302.1K · FY2007–10$500K$375K$250K$125K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$1,004,456 · 7
By mechanism
R43$840,156 · 6
R41$164,300 · 1
Investigators at Medros, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
High Throughput Drug Screening in Drosophila for Novel Diabetes Therapeutics$164,300
R41 · FY2007 · DK
Tunable Insulin Resistance in a Drosophila Model of Diabetes$152,114
R43 · FY2010 · DK
Establishing Drosophila Tools for Pathway Mapping and Target Identification$150,000
R43 · FY2010 · GM
Assessing Concentration Levels of Pharmacological Agents in Drosophila$137,071
R43 · FY2008 · GM
Using Drosophila to Screen p38 Inhibitors Targeted to the Liver as Novel Diabetes$136,313
R43 · FY2009 · DK
High Throughput Lethality Screen in Drosophila Against Tumor Metastasis$132,480
R43 · FY2008 · CA
High Throughput Drug Screening in Drosophila for Novel Cancer Therapeutics$132,178
R43 · FY2007 · CA